Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP177188E

Novus Biologicals™ SCRN2 Antibody Blocking Peptide
SDP

Catalog No. NBP177188E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP177188E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP177188E Supplier Novus Biologicals™ Supplier No. NBP177188PEP
Only null left
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A blocking peptide containing 18 amino acids near the carboxy terminus of human SCRN2. Source: Synthetic (Accession #: EAW94970) The SCRN2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 90507
Species Human
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-77188. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias secernin 2, secernin-2, Ses2
Gene Symbol SCRN2
Product Type SCRN2
Quantity 0.05 mg
Regulatory Status RUO - research use only
Source Synthetic
Termination 18 amino acids near the carboxy terminus of human SCRN2
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.